secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001193125-25-002537
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker to acquire Inari Medical for $80/share cash, ~$4.9B equity value
------------------------------------------------------------------------

- Stryker will pay $80 per share in cash for all outstanding Inari shares; total fully diluted equity value ~$4.9B.
- Transaction expands Stryker into peripheral vascular segment, adding VTE thrombectomy solutions.
- Boards of both companies unanimously approved; transaction expected to close by end of Q1 2025.
- Tender offer requires majority share minimum tender, HSR waiting period expiration, and other customary conditions.
- Inari (NARI) shareholders will receive $80/share; remaining shares acquired via second-step merger at same price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/0001193125-25-002537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/d899660d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-002537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer